Literature DB >> 21752645

3-(3-Phenoxybenzyl)amino-β-carboline: a novel antitumor drug targeting α-tubulin.

Reiko Ikeda1, Masaki Kurosawa, Takazumi Okabayashi, Ayako Takei, Masamichi Yoshiwara, Tadashi Kumakura, Norio Sakai, Osamu Funatsu, Akinori Morita, Masahiko Ikekita, Yumi Nakaike, Takeo Konakahara.   

Abstract

3-(3-Phenoxybenzyl)amino-β-carboline 2h showed extremely-high activity; the IC(50) value was 0.074 μM. To verify 2h-induced cell death types, we observed the chromatin condensation, the DNA fragmentation and activated caspase-3 using Hoechst 33342, agarose electrophoresis and western blot, and suggesting 2h-induced cell death type was apoptosis. Flow cytometry showed that 2h-treated cell was induced SubG1 cell population after G2/M cell cycle arrest. In addition, using affinity chromatography and peptide mass fingerprinting, we found that interacting protein with this compound was α-tubulin protein.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752645     DOI: 10.1016/j.bmcl.2011.06.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis and evaluation of new β-carboline-3-(4-benzylidene)-4H-oxazol-5-one derivatives as antitumor agents.

Authors:  Franciele Cristina Savariz; Mary Ann Foglio; João Ernesto de Carvalho; Ana Lúcia T G Ruiz; Marta C T Duarte; Mauricio Ferreira da Rosa; Emerson Meyer; Maria Helena Sarragiotto
Journal:  Molecules       Date:  2012-05-21       Impact factor: 4.411

2.  Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.

Authors:  Xiaofei Chen; Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang
Journal:  Molecules       Date:  2019-08-14       Impact factor: 4.411

3.  Synthesis and Biological Evaluation of Harmirins, Novel Harmine-Coumarin Hybrids as Potential Anticancer Agents.

Authors:  Kristina Pavić; Maja Beus; Goran Poje; Lidija Uzelac; Marijeta Kralj; Zrinka Rajić
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.